Trial · NCT00977938
Registered outcomes14
Each outcome the trial registered, primary first, in ClinicalTrials.gov's words.
1 to 14 of 14
Download this page as JSON| List | Outcome | Time frame | Description |
|---|---|---|---|
| Primary | MACCE (Death, Myocardial Infarction or Stroke) - Randomized DES ITT | 18 months (12-30 months post-index procedure) | The coprimary efficacy endpoints were the cumulative incidence of MACCE and the cumulative incidence of ARC definite or probable stent thrombosis within randomized DES ITT patients between 12 and 30 months post procedure. |
| Primary | Definite or Probable Stent Thrombosis (ST) - Randomized DES ITT | 18 months (12-30 months post-index procedure) | The coprimary efficacy endpoints were the cumulative incidence of MACCE and the cumulative incidence of definite or probable ST within randomized DES ITT patients between 12 and 30 months post procedure. ST was assessed according to the Academic Research Consortium (ARC) definitions. |
| Primary | GUSTO Severe or Moderate Bleeding - Randomized DES ITT | 18 months (12-30 months post-index procedure) | The primary safety endpoint was moderate or severe bleeding within randomized DES ITT patients between 12 and 30 months post procedure. Bleeding was assessed according to the Global Utilization of Streptokinase and Tissue Plasminogen Activator for Occluded Arteries (GUSTO) criteria. |
| Secondary | MACCE (Death, Myocardial Infarction or Stroke) - Propensity Matched DES vs. BMS | 33 months (0-33 months post-index procedure) | Secondary powered endpoint |
| Secondary | Definite or Probable Stent Thrombosis (ST) - Propensity Matched DES vs. BMS | 33 months (0-33 months post-index procedure) | Secondary powered endpoint |
| Secondary | MACCE (Death, Myocardial Infarction or Stroke) - Randomized DES ITT | 21 months (12-33 months post-index procedure) | |
| Secondary | Definite or Probable Stent Thrombosis (ST) - Randomized DES ITT | 21 months (12-33 months post-index procedure) | ST was assessed according to the Academic Research Consortium (ARC) definitions. |
| Secondary | GUSTO Severe or Moderate Bleeding - Randomized DES ITT | 21 months (12-33 months post-index procedure) | Bleeding was assessed according to the Global Utilization of Streptokinase and Tissue Plasminogen Activator for Occluded Arteries (GUSTO) criteria. |
| Secondary | MACCE (Death, Myocardial Infarction or Stroke) - Randomized BMS ITT | 18 months (12-30 months post-index procedure) | |
| Secondary | Definite or Probable Stent Thrombosis (ST) - Randomized BMS ITT | 18 months (12-30 months post-index procedure) | ST was assessed according to the Academic Research Consortium (ARC) definitions. |
| Secondary | GUSTO Severe or Moderate Bleeding - Randomized BMS ITT | 18 months (12-30 months post-index procedure) | Bleeding was assessed according to the Global Utilization of Streptokinase and Tissue Plasminogen Activator for Occluded Arteries (GUSTO) criteria. |
| Secondary | MACCE (Death, Myocardial Infarction or Stroke) - Randomized BMS ITT | 21 months (12-33 months post-index procedure) | |
| Secondary | Definite or Probable Stent Thrombosis (ST) - Randomized BMS ITT | 21 months (12-33 months post-index procedure) | ST was assessed according to the Academic Research Consortium (ARC) definitions. |
| Secondary | GUSTO Severe or Moderate Bleeding - Randomized BMS ITT | 21 months (12-33 months post-index procedure) | Bleeding was assessed according to the Global Utilization of Streptokinase and Tissue Plasminogen Activator for Occluded Arteries (GUSTO) criteria. |
Source ClinicalTrials.govtrials-2026-11-12-0.5.0
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/trials/v1/NCT00977938/registered